Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034787212> ?p ?o ?g. }
- W2034787212 endingPage "949" @default.
- W2034787212 startingPage "932" @default.
- W2034787212 abstract "Pacing and Clinical ElectrophysiologyVolume 15, Issue 6 p. 932-949 Defibrillation Threshold: Clinical Utility and Therapeutic Implications IGOR SINGER, Corresponding Author IGOR SINGER Cardiovascular Division, University of Louisville, Louisville, KentuckyAddress for reprints: Igor Singer, M.B.B.S., Director of Electro-physiology, University of Louisville. 550 South Jackson Street, Louisville'. KY 40292. Fax: (502) 588-7147.Search for more papers by this authorDOUG LANG, DOUG LANG Department of Research and Technology, Cardiac Pacemakers, Inc., St. Paul, MinnesotaSearch for more papers by this author IGOR SINGER, Corresponding Author IGOR SINGER Cardiovascular Division, University of Louisville, Louisville, KentuckyAddress for reprints: Igor Singer, M.B.B.S., Director of Electro-physiology, University of Louisville. 550 South Jackson Street, Louisville'. KY 40292. Fax: (502) 588-7147.Search for more papers by this authorDOUG LANG, DOUG LANG Department of Research and Technology, Cardiac Pacemakers, Inc., St. Paul, MinnesotaSearch for more papers by this author First published: June 1992 https://doi.org/10.1111/j.1540-8159.1992.tb03083.xCitations: 116AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Kouwenhoven WB, Milnor WR, Knickerbocker GG, et al. Closed-chest defibrillation of the heart. Surgery 1954; 42: 550. 2 Zoll PM, Linenthal AJ, Gibson W, et al. Termination of ventricular fibrillation in man by externally applied electric countershock. N Engl J Med 1956; 274: 727. 3 Lown BR, Arnarasingham R, Newman J, et al. New method for terminating cardiac arrhythmias; use of synchronized capacity discharge. J Am Med Assoc 1962; 182: 548. 4 Mower MM, Mirowski M, Spear JF, et al. Patterns of ventricular activity during catheter defibrillation. Circulation 1974; 49: 858. 5 Zipes DP, Fisher J, King RM, et al. Termination of ventricular fibrillation in dogs by depolarizing a critical amount of myocardium. Am J Cardiol 1975; 36: 37. 6 Shibata N, Chen PS, Dixon EG, et al. Epicardial activation after unsuccessful defibrillation shocks in dogs. Am J Physiol 1988; 255: H902. 7 Jones JL, Lepeschkin E, Jones RE, et al. Response of cultured myocardial cells to countershock-type electric field stimulation. Am J Physiol 1978; 235: H214. 8 Rubin L, Hudson P, Driller J, et al. Effect of defibrillation energy on pacing threshold. Med Instrum 1983; 17: 15. 9 Yabe S, Smith WM, Daubert JP, et al. Conduction disturbances caused by high current density electric fields. Circ Res 1990; 66: 1190. 10 Pansegrau DG, Abboud FM. Hemodynamic effects of ventricular defibrillation. J Clin Invest 1970; 49: 282. 11 Dahl CF, Ewy GA, Warner ED, et al. Myocardial necrosis from direct current countershock; Effect of paddle size and time interval between discharge. Circulation 1974; 50: 956. 12 Jones JL, Jones RE. Improved defibrillator waveform safety factor with biphasic waveforms. Am J Physiol 1983; 245: H60. 13 Winkle RA, Stinson EB, Bach SM Jr, et al. Measurement of cardioversion/defibrillation thresholds in man by a truncated exponential waveform and an apical patch-superior vena caval spring electrode configuration. Circulation 1984; 69: 766. 14 Thomas ED, Ewy GA, Dahl CF, et al. Effectiveness of direct current defibrillation: Role of paddle electrode size. Ann Heart J 1977; 93: 463. 15 Church T, Martinson M, Kalluk M, et al. A model to evaluate alternative methods of defibrillation threshold determination. PACE 1988: 11: 2002. 16 Davy JM, Fain ES, Dorian P, et al. The relationship between successful defibrillation and delivered energy in open-chest dogs: Reappraisal of the “de-fibrillation threshold” concept. Am Heart J 1987; 113: 77. 17 Dixon EG, Tang ASL, Wolf PD, et al. Improved de-fibrillation thresholds with large contoured epicar-dial electrodes and biphasic waveforms. Circulation 1987; 76: 1176. 18 McDaniel WC, Schuder JC. The cardiac ventricular defibrillation threshold—inherent limitations in its application and interpretation. Med Instrum 1987: 21: 170. 19 Lang DJ, Cato EL, Edit DS. Protocol for evaluation of internal defibrillation safety margins, (abstract) J Am Coll Cardiol 1989; 13(2); 111a. 20 Rattes MF, Jones DL, Sharma AD, et al. Defibrillation threshold: A simple and quantitative estimate of the ability to defibrillate. PACE 1987; 10: 70. 21 Davy JM, Fain ES, Dorian P, et al. The relationship between successful defibrillation and delivered energy in open-chest dogs: Reappraisal of the “defibrillation threshold” concept. Am Heart J 1987; 113: 77. 22 Lang DJ. Swanson DK. Safety margin for defibrillation. Presented at 2nd International Congress on Rate Adaptive Cardiac Pacing and Implantable De-fibrillators, October 1013, 1990, Munich, West Germany . 23 Jones DL, Klein GJ, Guiraudon GM, et al. Prediction of defibrillation success from a single defibrillation threshold measurement with sequential pulses and two current pathways in humans. Circulation 1988; 78: 1144. 24 Deeb GM, Griffith BP, Thompson ME, et al. Lead systems for internal ventricular defibrillation. Circulation 1981; 64: 242. 25 Mead RH, Ruder M, Schmidt P, et al. Improved defibrillation efficacy with chronically implanted defibrillation leads, (abstract) Circulation 1986; 74: 11– 110. 26 Echt DS, Barbey Jt, Black NJ. Influence of ventricular fibrillation duration on defibrillation energy in dogs using bidirectional energy in dogs using bidirectional pulse discharges. PACE 1988; 11: 1315. 27 Fujimura C, Jones DL, Klein GJ. Effects of time to defibrillation and subthreshold preshocks on defibrillation success in pigs. PACE 1989; 12: 358. 28 Jones JL, Swartz JF, Jones RE, et al. Increasing fibrillation duration enhances relative asymmetrical biphasic versus monophasic defibriltator waveform efficacy. Circ Res 1990; 67: 376. 29 Bardy GH, Stewart RS, Ivey TD, et al. Potential risk of low energy cardioversion attempts by implanta-ble cardioverters. J Am Coll Cardiol 1987; 9: 168A. 30 Bardy GH, Ivey TD, Allen M, et al. A prospective, randomized evaluation of effect of ventricular fibrillation duration on defbrillation thresholds in humans. J Am Coll Cardinl 1989: 13: 1362. 31 Bardy GH, Ivey TD, Johnson G, et al. Prospective evaluation of initialy ineffective defibrillation pulses on subsequent defibrillation success during ventricular fibrillation in survivors of cardiac arrest. Am J Cardiol 1988; 62: 718. 32 Stoddard MF, Labovitz AJ, Stevens LL, et al. Effects of electrophysiologic studies resulting in electrical countershock or burst pacing on left ventricular systolic and diastolic function, Am Heart J 1988; 116(2); 364. 33 Stoddard MF, Redd RR, Buckingham TA, et al. Effects of electrophysiologic testing of the automatic implantable cardioverter-defibrillator on left ventricular systolic function and diastolic filling. Am Heart J 1991; 122: 714. 34 Singer I, Edmonds HL, vander Laken C, et al. Is defibrillation testing safe PACE 1991: 14: 689(A). 35 Konstadt SN. Blakeman B, Wilber D, et al. The effects of normothermic hypoperfusion on processed EEG in patients. Aneth Analg 1990; 70: 213. 36 Fabiato PA, Coumel P, Gourgon R, et al. Le seuil de réponse synchrone des fibres myocardiques. Application a la comparaison experimentale de Pefficascite des differentes formes de chocs electriques de defibrillation. Arch Mal Coeur 1967; 60: 527. 37 Lesigne C, Levy B, Saumont R, et al. An energy-time analysis of ventricular fibrillation and defi-brillation thresholds with internal electrodes. Med Biol Eng 1976: 14: 617. 38 Chen P-S, Shibata N, Dixon EG, et al. Comparison of defibrillation threshold and the upper limit of ventricular vulnerability. Circulation 1986: 73: 1022. 39 Kavanaugh KM, Harrison JH, Dixon EG, et al. Correlation of the probability of success curves for de-fibrillation and for the upper limit of vulnerability. PACE 1990; 13: 536. 40 Chen P-S, Feld GK, Mower MM. et al. The effects of pacing rate and timing of shock on the relationship between defibrillation threshold and upper limit of vulnerability in open chest dogs. J Am Coll Car-diol 1991: 18(6): 1555. 41 Singer I, Guarnieri T, Kupersmith J. Implanted automatic defibrillators: Effects of drugs and pacemakers. PACE 1988; 11: 2250. 42 Fain ES, Dorian P, Davy JM, et al. Effects of encai-nide and its metabolites on energy requirements for defibrillation. Circulation 1986; 73: 1334. 43 Reiffel JA, Coromilas J, Zimmerman JM, et al. Drug-device interactions: Clinical considerations. PACE 1985; 8: 369. 44 Frame LH, Sheldon JH. Effect of recainam on the energy required for ventricular defibrillation in dogs as assessed with implanted electrodes. J Am Coll Cardiol 1988; 12: 746. 45 Dorian P, Fain ES, Davy JM, et al. Lidocaine causes a reversible, concentration-dependent increase in defibrillation energy requirements. J Am Coll Cardiol 1986; 8: 347. 46 Marinchak RA, Friehling TD, Line RA, et al. Effect of antiarrhythmic drugs on defibrillation threshold: Case report of an adverse effect of Mexiletine and review of the literature. PACE 1988; 11: 7. 47 Haberman RJ, Veltri EP, Mower MM. The effect of amiodarone on defibrillation threshold. J Electrophysiol 1988: 2: 415. 48 Fain ES, Lee JT, Winkle RA. Effects of acute intravenous and chronic oral amiodarone on defibrillation energy requirements. Am Heart J 1987: 114: 8. 49 Kentsch M, Kunze KP, Bleifeld W. Effect of intravenous amiodarone on ventricular fibrillation during out-of-hospital cardiac arrest, (abstract) J Am Coll Cardiol 1986; 7: 82A. 50 Fogoros RN. Amiodarone-induced refractoriness to cardioversion. Ann Intern Med 1984; 100: 699. 51 Guarnieri T, Levine JH, Veltri EP. Success of chronic defibrillation and the role of antiarrhythmic drugs with the automatic implantable cardioverter/defibrillator. Am J Cardiol 1987; 60: 1061. 52 Holt DW, Tucker GT, Jackson PR, et al. Amiodarone pharmacokinetics. Am Heart J 1983; 106: 840. 53 Barbieri E, Conti F, Zampieri P, et al. Amiodarone and desethylamiodarone distribution in the atrium and adipose tissue of patients undergoing short and long-term treatment with amiodarone. | Am Coll Cardiol 1986; 8: 210. 54 Dorian P, Fain ES, Davy JM, et al. Effect of quini-dine and bretylium on defibrillation energy requirements. Am Heart J 1986; 112: 19. 55 Deeb GM, Hardesty RL, Griffith BP, et al. The effects of cardiovascular drugs on the defibrillation threshold and the pathological effects on the heart using an automatic implantable defibrillator. Ann Thorac Surg 1983; 4: 361. 56 Woolfolk DI, Chaffee WR, Cohen W. et al. The effect of quinidine on electrical energy required for ventricular defibrillation. Am Heart J 1966; 72: 659. 57 Babbs CF, Yim GKW, Whistler SJ, et al. Elevation of ventricular defibrillation energy requirements, Am Heart J 1986; 112: 19. 58 Koo CC, Allen JD, Pantridge JF. Lack of effect of bretylium tosylate on electrical ventricular defibrillation in a controlled study. Cardiovasc Res 1984; 18: 762. 59 Kerber RE, Pandian NG, Jensen SR, et al. Effect of lidocaine and bretylium on energy requirements for transthoracic defibrillation: Experimental studies. J Am Coll Cardio! 1986; 7: 397. 60 Tacker WA, Nieballer MJ, Babbs CF, et al. The effect of newer antiarrhythmic drugs on defibrillation threshold. Crit Care Med 1980; 8: 177. 61 Dawson AK, Steinberg MI, Shephard JE. Effects of Class I and Class III drugs or current and energy required for internal defibrillation. (abstract) Circulation 1985; 72: 111– 384. 62 Ruffy R, Schechtman K, Monje E, et al. B-adrener-gic modulation of direct defibrillation energy in anesthetized dog heart. Am J Physiol 1985; 248(17): H674. 63 Ruffy R, Monje E, Schechtman K. Facilitation of cardiac defibrillation by aminophylline in the conscious, closed-chest dog. J Electrophysiol 1988; 2: 450. 64 Schuder JC, Stoeckle H, Dolan AM. Transthoracic ventricular defibrillation with square-wave stimuli: One-half cycle, one cycle, and multicycle wave-forms. Circ Res 1964; 15: 258. 65 Schuder JC, McDaniel WC, Stoeckle H. Transthoracic defibrillation of 100 kg calves with bidirectional truncated exponential shocks. Trans Am Soc Artif Intern Organs 1984; 30: 520. 66 Schuder JC, Gold JH, Stoeckle H, et al. Defibrillation in the calf with bidirectional trapezoidal wave shocks applied via chronically implanted epicar-dial electrodes. Trans Am Soc Artif Organs 1981; 27: 467. 67 Dixon EG, Tang ASL, Wolf PD, et al. Improved de-fibrillation thresholds with large contoured epicar-dial electrodes and biphasic waveforms. Circulation 1987; 76: 1176. 68 Tang ASL, Yabe S, Wharton JM, et al. Ventricular defibrillation using biphasic waveforms: The importance of phasic duration. J Am Coll Cardiol 1989; 13: 207. 69 Winkle RA, Mead RM, Ruder MA, et al. Improved low energy defibrillation efficacy in man with the use of a biphasic truncated exponential waveform. Am Heart J 1989; 117: 122. 70 Bardy GH. Ivey TD, Allen MD, et al. A prospective randomized evaluation of biphasic versus mono-phasic waveform pulses on defibrillation efficacy in humans. J Am Coll Cardiol 1989: 14: 728. 71 Kavanaugh KM, Tang ASL, Rollins DL, et al. Comparison of the internal defibrillation thresholds for monophasic and clinical and single capacitor biphasic waveforms. J Am Coll Cardiol 1989; 14(5): 1343. 72 Jones JL, Jones RE, Balasky GE. Improved cardiac cell excitation with symmetrical biphasic defibrillation waveforms. Am J Physiol 1987; 253: M1418. 73 Swartz JF, Jones JL, Jones RE, et al. Diphasic waveforms enhance defibrillation success by prolonging refractoriness in defibrillating wavelengths, (abstract) J Am Coll Cardiol 1990; 15(2); 72A. 74 Kallok MJ, Marcaccini S. Efficacy of two transve-nous electrode systems for sequential pulse defibritlation. In FP Gomez (ed.): Cardiac Pacing: Electrophysiology; Tachyarrhythmias. Madrid , Spain , Editorial Grouz, 1985, p. 1497. 75 Jones DL, Klein GJ, Guiraudon GM, et al. Sequential pulse defibrillation in humans: Orthogonal sequential pulse defibrillation with epicardial electrodes. J Am Coll Cardiol 1988: 13: 590. 76 Chang MS, Inoue H, Kallok MJ, et al. Double and triple sequential shocks reduce ventricular defibrillation threshold in dogs with and without myo-cardial infarction. J Am Col! Cardiol 1986; 8: 1393. 77 Wetherbee JN, Chapman PD, Bach SM, et al. Sequential shocks are comparable to single shocks employing two current pathways for internal defibrillation in dogs. PACE 1988; 11: 696. 78 Singer I, Maldonado C, Vance F, et al. Defibrillation efficacy using two low profile electrodes. Am J Med Sci 1991; 302(2): 82. 79 Singer I, Maldonado C. Scott C., et al. Permanent Accufix DFR and BEDLR electrodes for transvenous defibrillation in the canine model. In GE Anto-neoli, AE Aubert, H Ector (eds.): Proceedings of the Second International Symposium on Pacing Leads. New York , NY , Elsevier Publishers, 1991, p. 309. 80 Schuder JC, Stoeckle H, McDaniel JD. Is the effectiveness of cardiac ventricular defibrillation dependent on polarity Med Instrumen 1987; 21(5): 262. 81 Rubin L, Hudson P, Driller J, et al. Automatic defibrillation and pacing with transvenous electrode. In: Proceedings of the Fourth Annual New England Biomedical Engineering Conference. 1976, p. 427. 82 Troup PJ. Implantable cardioverters and defibrillators. In RA O'Rourke, MH Crawford (eds.): Current Problems in Cardiology. St. Louis , MO , Yearbook Medical Publishers, Inc., 1989, Vol. XIV(12). p. 798. 83 Tang ASL, Wharton JM, Baker RG, et al. Ventricular defibrillation using biphasic waveforms of different phasic durations. PACE 1987; 10: 417. 84 Brodman R, Fisher JD, Furman S, et al. Implantation of the automatic implantable defibrillator by left subcostal thoracotomy. PACE 1984; 7: 1370. 85 Thurer RJ, Luceri RM, Balooki H. Automatic implantable cardioverter defibrillator: Techniques of implantation and results. Ann Thorac Surg 1986; 43: 143. 86 Lawrie GM, Griffin JC, Wyndham CRC. Epicardial implantation of the automatic defibrillator by left subcostal thoracotomy. PACE 1984; 7: 1370. 87 Echt DS, Armstrong K, Schmidt P, et al. Clinical experience, complication, and survival in 70 patients with the automatic cardioverter/defibrilla-tor. Circulation 1985; 71: 289. Citing Literature Volume15, Issue6June 1992Pages 932-949 ReferencesRelatedInformation" @default.
- W2034787212 created "2016-06-24" @default.
- W2034787212 creator A5040525924 @default.
- W2034787212 creator A5066146237 @default.
- W2034787212 date "1992-06-01" @default.
- W2034787212 modified "2023-09-27" @default.
- W2034787212 title "Defibrillation Threshold: Clinical Utility and Therapeutic Implications" @default.
- W2034787212 cites W1963500182 @default.
- W2034787212 cites W1966350948 @default.
- W2034787212 cites W1971180556 @default.
- W2034787212 cites W1971919495 @default.
- W2034787212 cites W1973098096 @default.
- W2034787212 cites W1974209513 @default.
- W2034787212 cites W1981025912 @default.
- W2034787212 cites W1986694240 @default.
- W2034787212 cites W1991990589 @default.
- W2034787212 cites W1995244903 @default.
- W2034787212 cites W1995359977 @default.
- W2034787212 cites W1995652171 @default.
- W2034787212 cites W1996302487 @default.
- W2034787212 cites W2002069669 @default.
- W2034787212 cites W2004726965 @default.
- W2034787212 cites W2007535687 @default.
- W2034787212 cites W2008044258 @default.
- W2034787212 cites W2010133380 @default.
- W2034787212 cites W2010694435 @default.
- W2034787212 cites W2012260289 @default.
- W2034787212 cites W2015146179 @default.
- W2034787212 cites W2015204665 @default.
- W2034787212 cites W2017266433 @default.
- W2034787212 cites W2018070883 @default.
- W2034787212 cites W2018328437 @default.
- W2034787212 cites W2023759685 @default.
- W2034787212 cites W2025184967 @default.
- W2034787212 cites W2027040058 @default.
- W2034787212 cites W2029053848 @default.
- W2034787212 cites W2032082890 @default.
- W2034787212 cites W2035053023 @default.
- W2034787212 cites W2035951469 @default.
- W2034787212 cites W2039566279 @default.
- W2034787212 cites W2040978157 @default.
- W2034787212 cites W2041800048 @default.
- W2034787212 cites W2047633698 @default.
- W2034787212 cites W2055074969 @default.
- W2034787212 cites W2058236658 @default.
- W2034787212 cites W2065002331 @default.
- W2034787212 cites W2068287464 @default.
- W2034787212 cites W2068303597 @default.
- W2034787212 cites W2069083629 @default.
- W2034787212 cites W2071155157 @default.
- W2034787212 cites W2071478770 @default.
- W2034787212 cites W2078185496 @default.
- W2034787212 cites W2085922894 @default.
- W2034787212 cites W2088611292 @default.
- W2034787212 cites W2090942824 @default.
- W2034787212 cites W2107840540 @default.
- W2034787212 cites W2115941009 @default.
- W2034787212 cites W2134946429 @default.
- W2034787212 cites W2135310004 @default.
- W2034787212 cites W2150495469 @default.
- W2034787212 cites W2159208818 @default.
- W2034787212 cites W2330792439 @default.
- W2034787212 cites W2339045148 @default.
- W2034787212 cites W2418936923 @default.
- W2034787212 cites W4233704600 @default.
- W2034787212 cites W4254785960 @default.
- W2034787212 doi "https://doi.org/10.1111/j.1540-8159.1992.tb03083.x" @default.
- W2034787212 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1376905" @default.
- W2034787212 hasPublicationYear "1992" @default.
- W2034787212 type Work @default.
- W2034787212 sameAs 2034787212 @default.
- W2034787212 citedByCount "135" @default.
- W2034787212 countsByYear W20347872122012 @default.
- W2034787212 countsByYear W20347872122013 @default.
- W2034787212 countsByYear W20347872122014 @default.
- W2034787212 countsByYear W20347872122015 @default.
- W2034787212 countsByYear W20347872122017 @default.
- W2034787212 countsByYear W20347872122020 @default.
- W2034787212 countsByYear W20347872122021 @default.
- W2034787212 countsByYear W20347872122023 @default.
- W2034787212 crossrefType "journal-article" @default.
- W2034787212 hasAuthorship W2034787212A5040525924 @default.
- W2034787212 hasAuthorship W2034787212A5066146237 @default.
- W2034787212 hasConcept C164705383 @default.
- W2034787212 hasConcept C177713679 @default.
- W2034787212 hasConcept C2777795826 @default.
- W2034787212 hasConcept C2778002379 @default.
- W2034787212 hasConcept C545542383 @default.
- W2034787212 hasConcept C71924100 @default.
- W2034787212 hasConceptScore W2034787212C164705383 @default.
- W2034787212 hasConceptScore W2034787212C177713679 @default.
- W2034787212 hasConceptScore W2034787212C2777795826 @default.
- W2034787212 hasConceptScore W2034787212C2778002379 @default.
- W2034787212 hasConceptScore W2034787212C545542383 @default.
- W2034787212 hasConceptScore W2034787212C71924100 @default.
- W2034787212 hasIssue "6" @default.
- W2034787212 hasLocation W20347872121 @default.
- W2034787212 hasLocation W20347872122 @default.